153 related articles for article (PubMed ID: 21504714)
41. Detection of a Cryptic EP300/ZNF384 Gene Fusion by Chromosomal Microarray and Next-Generation Sequencing Studies in a Pediatric Patient with B-Lymphoblastic Leukemia.
Berg HE; Blackburn PR; Smadbeck JB; Swanson KE; Rice CS; Webley MR; Johnson SH; Vasmatzis G; Xu X; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Boston CH; Sutton LM; Peterson JF
Lab Med; 2021 May; 52(3):297-302. PubMed ID: 33145596
[TBL] [Abstract][Full Text] [Related]
42. BCR-PDGFRA fusion in a T lymphoblastic leukemia/lymphoma.
Yigit N; Wu WW; Subramaniyam S; Mathew S; Geyer JT
Cancer Genet; 2015; 208(7-8):404-7. PubMed ID: 26095243
[TBL] [Abstract][Full Text] [Related]
43. Systematic application of fluorescence in situ hybridization and immunophenotype profile for the identification of ZNF384 gene rearrangements in B cell acute lymphoblastic leukemia.
Janet NB; Kulkarni U; Arun AK; Bensega B; Devasia AJ; Korula A; Abraham A; George B; Mathews V; Balasubramanian P
Int J Lab Hematol; 2021 Aug; 43(4):658-663. PubMed ID: 33988307
[TBL] [Abstract][Full Text] [Related]
44. Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP.
Qian M; Zhang H; Kham SK; Liu S; Jiang C; Zhao X; Lu Y; Goodings C; Lin TN; Zhang R; Moriyama T; Yin Z; Li Z; Quah TC; Ariffin H; Tan AM; Shen S; Bhojwani D; Hu S; Chen S; Zheng H; Pui CH; Yeoh AE; Yang JJ
Genome Res; 2017 Feb; 27(2):185-195. PubMed ID: 27903646
[TBL] [Abstract][Full Text] [Related]
45. Detection of EP300-ZNF384 fusion in patients with acute lymphoblastic leukemia using RNA fusion gene panel sequencing.
Jing Y; Li YF; Wan H; Liu DH
Ann Hematol; 2020 Nov; 99(11):2611-2617. PubMed ID: 32980888
[TBL] [Abstract][Full Text] [Related]
46. Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19.
Inukai T; Hirose K; Inaba T; Kurosawa H; Hama A; Inada H; Chin M; Nagatoshi Y; Ohtsuka Y; Oda M; Goto H; Endo M; Morimoto A; Imaizumi M; Kawamura N; Miyajima Y; Ohtake M; Miyaji R; Saito M; Tawa A; Yanai F; Goi K; Nakazawa S; Sugita K
Leukemia; 2007 Feb; 21(2):288-96. PubMed ID: 17183364
[TBL] [Abstract][Full Text] [Related]
47. EP300-ZNF384 fusion gene product up-regulates GATA3 gene expression and induces hematopoietic stem cell gene expression signature in B-cell precursor acute lymphoblastic leukemia cells.
Yaguchi A; Ishibashi T; Terada K; Ueno-Yokohata H; Saito Y; Fujimura J; Shimizu T; Ohki K; Manabe A; Kiyokawa N
Int J Hematol; 2017 Aug; 106(2):269-281. PubMed ID: 28378055
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic utility of molecular investigation in extraskeletal myxoid chondrosarcoma.
Benini S; Cocchi S; Gamberi G; Magagnoli G; Vogel D; Ghinelli C; Righi A; Picci P; Alberghini M; Gambarotti M
J Mol Diagn; 2014 May; 16(3):314-23. PubMed ID: 24508382
[TBL] [Abstract][Full Text] [Related]
49. Novel t(2;12)(q31;p13) in a case of pediatric T-cell acute lymphoblastic leukemia.
Parihar M; Gupta A; Remani AS; Bhattacharyya A; Mishra DK; Chandy M
J Pediatr Hematol Oncol; 2014 Jul; 36(5):e313-5. PubMed ID: 24577543
[TBL] [Abstract][Full Text] [Related]
50. FOXP1 and PAX5 are rare but recurrent translocations partners in acute lymphoblastic leukemia.
Put N; Deeren D; Michaux L; Vandenberghe P
Cancer Genet; 2011 Aug; 204(8):462-4. PubMed ID: 21962897
[TBL] [Abstract][Full Text] [Related]
51. Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression.
McClure BJ; Heatley SL; Kok CH; Sadras T; An J; Hughes TP; Lock RB; Yeung D; Sutton R; White DL
Br J Cancer; 2018 Apr; 118(7):1000-1004. PubMed ID: 29531323
[TBL] [Abstract][Full Text] [Related]
52. Zinc finger protein 384 (
Sudutan T; Erbilgin Y; Hatirnaz Ng O; Karaman S; Karakas Z; Kucukcankurt F; Celkan T; Timur C; Ozdemir GN; Hacısalihoglu S; Gelen SA; Sayitoğlu M
Leuk Lymphoma; 2022 Dec; 63(12):2931-2939. PubMed ID: 35921545
[TBL] [Abstract][Full Text] [Related]
53. ATF7IP as a novel PDGFRB fusion partner in acute lymphoblastic leukaemia in children.
Kobayashi K; Mitsui K; Ichikawa H; Nakabayashi K; Matsuoka M; Kojima Y; Takahashi H; Iijima K; Ootsubo K; Oboki K; Okita H; Yasuda K; Sakamoto H; Hata K; Yoshida T; Matsumoto K; Kiyokawa N; Ohara A
Br J Haematol; 2014 Jun; 165(6):836-41. PubMed ID: 24628626
[TBL] [Abstract][Full Text] [Related]
54. [Molecular cytogenetic characterization of five patients with myeloid leukemia and t(12;22)(p13;q12)].
Shao H; Yang Q; Gong Y; Bai S; Zhang J; Wang Y; Shen J; Wu C; Qiu H; Chen S; Pan J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Feb; 36(2):112-115. PubMed ID: 30703225
[TBL] [Abstract][Full Text] [Related]
55. Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients.
Bohlander SK; Muschinsky V; Schrader K; Siebert R; Schlegelberger B; Harder L; Schemmel V; Fonatsch C; Ludwig WD; Hiddemann W; Dreyling MH
Leukemia; 2000 Jan; 14(1):93-9. PubMed ID: 10637482
[TBL] [Abstract][Full Text] [Related]
56. [Analysis of Clinical Characteristics of Acute B Lymphoblastic Leukemia with EP300-ZNF384 Fusion Gene Positive].
Yao ZL; Li YF; Li M; Li Y; Li WJ; Li HH; Liu YY; Lin SH; Li FW; Zhang J; Jing Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):24-28. PubMed ID: 32027248
[TBL] [Abstract][Full Text] [Related]
57. ZNF384-Related Fusion Genes in Acute Lymphoblastic Leukemia.
Zhu L; Bai W; Cheng Q; Fang J
Cancer Control; 2023; 30():10732748231182787. PubMed ID: 37306722
[TBL] [Abstract][Full Text] [Related]
58. Acute lymphoblastic leukemia with infrequent ARID1B::ZNF384 gene fusion simulating multifocal osteomyelitis.
Long F; Li T; Zhang Y; Gao X; Wang H; Huang X
Pediatr Blood Cancer; 2023 Oct; 70(10):e30514. PubMed ID: 37336773
[No Abstract] [Full Text] [Related]
59. Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia.
Oberley MJ; Gaynon PS; Bhojwani D; Pulsipher MA; Gardner RA; Hiemenz MC; Ji J; Han J; O'Gorman MRG; Wayne AS; Raca G
Pediatr Blood Cancer; 2018 Sep; 65(9):e27265. PubMed ID: 29797659
[TBL] [Abstract][Full Text] [Related]
60. NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas.
Brenca M; Stacchiotti S; Fassetta K; Sbaraglia M; Janjusevic M; Racanelli D; Polano M; Rossi S; Brich S; Dagrada GP; Collini P; Colombo C; Gronchi A; Astolfi A; Indio V; Pantaleo MA; Picci P; Casali PG; Dei Tos AP; Pilotti S; Maestro R
J Pathol; 2019 Sep; 249(1):90-101. PubMed ID: 31020999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
